Biosensor Biocompatibility
Biosensor Biocompatibility
批准号:
7483899
负责人:
William Montgomery Reichert
金额:
$6.51万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-07-01 至 2008-06-30
关键词:
AddressAmericanAngiogenic FactorAnti-Inflammatory AgentsAnti-inflammatoryAntibodiesAttenuatedBedsBinding ProteinsBiological AssayBiological MarkersBiosensorBloodBoxingCalibrationCardiacCollaborationsCollectionConditionConditioned Culture MediaCustomDepositionDetectionDevelopmentDevicesDexamethasoneDorsalEnzymesFailureFibrosisFingersFluoroimmunoassayGeneric DrugsGlassGlucoseGrowth FactorHealedHistologicHistologyHuman ResourcesHydrogelsIL8 geneImmunoblottingImplantIn VitroInflammationInflammatoryInsulinInterleukin-1 ReceptorsInterleukin-10Interleukin-4Interleukin-6InterventionLabelLinkMediator of activation proteinMembraneMethodsMicrodialysisMicrospheresModelingModificationMoldsMolecular WeightNamesNumbersPGLAPerformancePharmaceutical PreparationsPlatelet-Derived Growth FactorPolystyrenesPrincipal InvestigatorPrintingProtein ArrayProteinsProtocols documentationRangeRattusRecoveryReportingResearch PersonnelResearch Project GrantsResistanceSamplingScienceSiteSolutionsSpottingsStagingStandards of Weights and MeasuresSteroidsSubcutaneous TissueSystemTestingTimeTissuesTodayTreatment ProtocolsUniversitiesUtahVascular Endothelial Growth FactorsVisitWeekWound Healingangiogenesisbasebiomaterial compatibilityclinically significantcytokinedaydensitydiabeticfallsglucose monitorglucose sensorglucose transporthealingimplantationimplanted sensorin vivomacrophageneovascularizationprogramsprophylacticsensorwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Clinical significance Several groupshave reported glucose sensorsthat have hctionedsuccessf'ully for weeks
to months in vivo;however, none of these sensors appear capable of reliablv surviving long-term implantation.
Our global hypothesis is that membrane modifications and local release strategies that resist biofouling,
attenuate inflammation, and reduce the fibrosity and avascularity of the surrounding wound healing tissue will
minimize impediments to glucose transport across the sensor membrane. The short term strategy is to examine
the effect of anti-intlammatory steroids and/or angiogenic growth factor release on glucose transport to the
sensor. Although likely to be effective mediators, we further hypothesize that these approaches are monolithic
and prophylactic in their action. In the long term, the highest level of wound healing intervention would be to
directly manipulate the macrophages residing in the wound healing tissue surrounding implanted sensor.
Currently, the information base necessary to propose a macrophage-centered strategy does not exist. This
project therefore takes the first step in this direction: determining the temporal profile of key intlammatory and
reparative macrophage-derived cytokines in the sensor implant site.
Experimental approach Microdialysis probes implanted in dorsal rat subcutis will be used as a real time
method to (1) characterize the transport of glucose across implanted sensor membranes that have been treated
to resist biofouling and increase vascularity of the tissue surrounding the implanted probe; and (2) collect
cytokines &om the wound healing tissue surrounding the implanted probes. The collected glucose and
cytokines will be analyzed by a commercial enzyme-linked microanalyzer and a custom-made antibody array,
respectively. The target cytokines are basic-FGF, PDGF, TNF-a,TGF-P, IL-1 receptor antagonist, and IL-1P,
IL-4, IL-6, IL-8 and IL-10, all of which are macrophage-derived mediators of wound healing and inflammation.
Correlation between the temporal composition of the cytokine profile, the acquisition of glucose, and the
histology of the wound healing tissue under various membrane treatments will be used to: (1) develop a cause-
and-effect understandings of sensor membrane modifications on access to blood borne analytes, and (2) assess
the participationof macrophages in the wound healing-related decay of implanted sensor performance.
~
'ERFORMANCESITE(S)(organization, c@, state)
Duke University
Department of BiomedicalEngineering
Campus Box 90281
Durham, NC 27708-0281
KEY PERSONNEL. See instructionson Page 11. Usecontinuationpages as needed to providethe requiredinformation intheformat shmbelow
me Orqanization Roleon Project
WILLIAM M. REICHERT DUKE UNIVERSITY PRINCIPAL
INVESTIGATOR
BRUCE KLITZMAN DUKE UNIVERSITY INVESTIGATOR
FAN YUAN DUKE UNIVERSITY INVESTIGATOR
YIWEN LI DUKE UNIVERSITY VISITING SCHOLAR
PHS 390 (Rev 5/95) Paoe 2 BB
cc PrincipalInvestigator/ProgramDirector (Last, first, middle): Reichert. William
Type the name of the principal investigator/program director at the top of each printed page and each continuation page. (For type specifications, see
instructionson page6.)
RESEARCH GRANT
TABLE OF CONTENTS
Page Numbers
FacePage......................................................................................................... ............................................. 1
Description,
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Self Healing Biomaterials
-
批准号:8183634
-
项目类别:
-
资助金额:$19.14万
-
财政年份:2011
-
负责人:William Montgomery Reichert
-
依托单位:
Self Healing Biomaterials
-
批准号:8296282
-
项目类别:
-
资助金额:$19.12万
-
财政年份:2011
-
负责人:William Montgomery Reichert
-
依托单位:
2009 Biomaterials Gordon Research Conference
-
批准号:7612857
-
项目类别:
-
资助金额:$1.0万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:7848575
-
项目类别:
-
资助金额:$1.03万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:8270014
-
项目类别:
-
资助金额:$27.31万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:8320039
-
项目类别:
-
资助金额:$4.03万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:7654124
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:8066625
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
EPC Adhesion to Teflon-AF and ePTFE Vascular Grafts
-
批准号:7822958
-
项目类别:
-
资助金额:$23.4万
-
财政年份:2009
-
负责人:William Montgomery Reichert
-
依托单位:
Functional Neuron-Glial in Vitro Assay for Implantable Neuroelectrodes
-
批准号:7464531
-
项目类别:
-
资助金额:$20.21万
-
财政年份:2008
-
负责人:William Montgomery Reichert
-
依托单位:
Functional Neuron-Glial in Vitro Assay for Implantable Neuroelectrodes
-
批准号:7614165
-
项目类别:
-
资助金额:$13.65万
-
财政年份:2008
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:8292107
-
项目类别:
-
资助金额:$37.48万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:8080187
-
项目类别:
-
资助金额:$37.54万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
BIOSENSOR BIOCOMPATIBILITY
-
批准号:6138092
-
项目类别:
-
资助金额:$23.83万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
BIOSENSOR BIOCOMPATIBILITY
-
批准号:6414095
-
项目类别:
-
资助金额:$1.5万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:7623657
-
项目类别:
-
资助金额:$25.8万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:7250897
-
项目类别:
-
资助金额:$23.73万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:6917084
-
项目类别:
-
资助金额:$31.12万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
BIOSENSOR BIOCOMPATIBILITY
-
批准号:6589918
-
项目类别:
-
资助金额:$4.0万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
Biosensor Biocompatibility
-
批准号:7737459
-
项目类别:
-
资助金额:$41.59万
-
财政年份:1999
-
负责人:William Montgomery Reichert
-
依托单位:
海外基金